A method is described that, on the basis of the time course of amidolytic activity after the triggering of thrombin generation in normal plasma, allows the calculation of the velocity of prothrombin conversion independent of thrombin inactivating processes.
The classical thrombin generation test suffers from an important drawback: the samples from the mixture in which thrombin is generated have to be tested immediately on a fibrinogen containing reagent. Estimation of low concentrations of thrombin tends to be very imprecise and time-consuming when clotting methods are used. It therefore is virtually impossible to achieve in this way a sampling pattern with enough measuring points and of sufficient accuracy over the whole time range. A detailed analysis of the thrombin generation curve obtained by this method is therefore impossible.
This article describes a method to obtain thrombin generation curves with sampling intervals that can be as small as 5 sec. The thrombin is measured by its action on a chromogenic substrate. It is shown how these curves can be used to compute the time course of the process that generates thrombin (prothrombinase) independently of the processes that inactivate thrombin (antithrombins). These calculations can be carried out with the aid of a personal computer.
The following abbrevations will be used: AT III : Antithrombin III; u2M : o2-macroglobulin; Tiis : tris (hydroxymethyl)-aminomethane; EDTA : Ethylenediamino tetracetate; SBTI : Soybean Tiypsin Inhibitor.
Materials and Methods

Plasmas
Blood from healthy donors was collected on 0.13 M trisodium citrate; nine parts of blood to one part of citrate solution.
A first and a second centrifugation were performed at 3,000 g, at 15' C for 15 min. A third centrifugation was done at 4" C, for one hour at 23,000 g. The platelet free plasma thus obtained was stored at -80" C. It was checked that the clotting factors and the antiproteases were in the normal range. The clotting factors were determined according to refs. 11 and 12. Radial immuno diffusion was used to estimate o2-macroglobulin and a1-antitrypsin (M. Partigen, Behring Werke, Germany). Antithrombin III was determined according to ref. 13 .
Defibrinated plasma was obtained by mixing an aliquot of plasma with 1:500 volume of a reptilase solution, letting a clot form for 10 min at 37" C and keeping the clotted plasma at 0" C for 10 min. The fibrin formed was discarded by centrifugation (10 min, 5000 g, 0" C) or by winding on a small plastic spatula. The concentrations of factors II, V, VII, VIII, IX, X, XI, and XII did not significantly change by the reptilase treatment. For the factors V and VIII series of dilutions (1 10%) of the plasma before and after the treatment were compared. They showed clotting times that were identical within the limits of experimental error thus excluding the possibility that a combined effect of activation and inactivation of the factors accidently mimicked as identical clotting factors.
The euglobulin fraction from defibrinated plasma was obtained by acid precipitation at low ionic strength as described in ref. 11 . The precipitate was dissolved in Michaelis buffer pH 7.35 containing 0.02 M trisodium citrate, so as to obtain a concentration of the clotting factor II, V VII and X that was not lower than 50%. No antithrombin activity could be demonstrated in this mixture.
Thrombin was formed in the euglobulin fraction by the addition of human thromboplastin (1,:240 final diiution) and CaC12 (16 mM final conc.). The development of thrombin activity was measured as described later in this section.
Human brain thromboplastin was prepared as described in ref.
14. It was subsequently centrifuged at 2000 g for 15 min and stored in 0.1 ml aliquots at -20' C. It was thawed and incubated at 37" C for one hour, then diluted as indicated with buffer A containing 100 mM of CaC12 and kept at room temperature. In this way it remained stable for at least 4 h.
Reptilase was obtained from Laboratories Stago (Asnidres, France), and prepared according to the indications of the manufacturet.
Soybean trypsin inhibitor (batch no 43 F-800) was obtained from Sigma (St. Louis, USA). A 10 mg/ml solution in buffer A was used.
Staphylocoagulase was prepared as described in Hendrix et al. (15) . Chromogenic substrate for thrombin was H.D.-phe-pip-arg-pNA. 2 HCL (52238, from Kabi, Sweden).
Other chemicals were the highest grade commercially available' Buffers A: 0.05 M Tiis-HCl, 0.1 M NaCl pH 7.5, with 0.5% egg albumin (Sigma) B: Buffer A with 20 mM EDTA.
I nhib ito r-D eficient P las mas Plasma without o2M was obtained by addition of anti-o2M globulin to normal plasma and elimination of the immunoprecipitate. The y-globulins were isolated according to Steinbuch et ai. (16) from the serum of rabbits immunized against purified human cr2M (gift from J. Tapon-Bretaudidre). No o2M could be demonstrated by an immunoelectrophoretic method that would detect o2M at concentrations )2"k of the normal plasma concentration. Plasma without AT III was prepared by gently stirring 2 ml of normal human plasma with 0.8 mt of a slurry of sepharose to which anti ATIII was bound (gift from Dr. Tian Huu Tii, Basel) for 18 h at 4" C. The antithrombin activity in the plasma after adsorbtion was not influenced by the addition of 1 U/ml of heparin.
Determination of the Time Course of Amidolytic Activity
An aliquot of plasma is defibrinated as indicated above. To 200 pl of defibrinated plasma is added 50 pl of buffer A, that may contain the substances of which the influence on thrombin generation has to be investigated (e. g. heparins).
At zero time, thrombin generation is triggered by the addition of 50 pl buffer A containing 100 mM of CaC12 and a suitable trigger of coagulation. In the experiments described here human brain thromboplastin, diiuted as indicated, was used as a trigger. If necessary the volumes indicated may be proportionally altered. At fixed intervals (10, 15, 20, 30 or 60 sec) after zero time, a 10 pl aliquot of the mixture is added to a disposable plastic microcuvette containing 465 pti of buffer B and 25 pl of a 4 mM solution of S 2238 ar 37' C.
The aliquots are handled with a Microman pipette (Gilson, France). It is essential to keep the plunger of the pipette down after subsampling and to wipe the pipette tip carefully in order to avoid contamination of the incubation mixtures with EDTA from the buffer in the cuvette. Plastic tubes can be used instead of cuvettes but slass tubes adsorb thrombin and give unpredictable results.
A 15 sec rhythm is easiiy managed, 10 sec intervals require some practice. If shorter intewals are required one can make use of pipettes equipped with a pushbutton connected to an input gate of a personai computer (Apple IIe) programmed to record the moment of sampling. After sampiing the cuvette is quickly and rigorously mixed on a Vortex mixer. After 120 sec.the reaction in the cuvette is stopped by adding 0.3 ml of concentrated (98%) acetic acid, the cuvette is again thoroughly mixed and can be kept at room temperature until reading. If a pushbutton pipette and automatic time recording is used for sampling, then stopping the reaction is also carried out with a time recording pipette.
The cuvettes are read at 405 nM in a suitable spectrophotometer (LKB-Ultrospec). The generation of p-Nitroaniline was linear in time up to an O.D. of 0.900. If necessary, incubation times longer or shorter than two minutes can be used so as to obtain a suitable sensitivitv and not to erceed 0.9 O.D.
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The thrombin concentration data are processed by a computer program to obtain the time course of prothrombin conversion velocity. A full description of this procedure is to be found in the annexe.
Determination of the Thrombin Breakdown Constant
The same mixture as for thrombin generation curves is used, but with a volume of 44 ttl of buffer A instead of 50 pl. After 2 to B min, at a moment that sufficient thrombin is formed, 6 pl of SBTI solution (10 mg/ ml) is added to the main incubation mixture, so as to stop further prothrombinase activity. SBTI at this concentration could be shown to stop completely the activity of prothrombinase and not to influence the amidolytic activity of thrombin (17) .
At the shortest possible intervals after addition of the SBTI solution, 10 pl aliquots of the incubation mixture were added to cuvettes by the use of a time recording pipette. The cuvettes were further treated as described for the thrombin generation curves.
Activ ation by S tap hy loco agulas e A solution of staphylocoagulase of 50 nM is used. Of this solution 100 pl was added to 100 pl of a suitably diluted plasma sample. Normal plasma can be diluted 1:50. The incubation mixture remaining after a thrombin generation experiment is best diluted I :5 or 1:10. The thrombin activity resulting from the formation of coagulase-thrombin is measured by adding 10 pl of the. mixture to a cuvette containing buffer B and chromogenic substrate as used for the thrombin generation curves. The staphylocoagulase-prothrombin complex has the same molar activity towards small molecular weight substrates as thrombin (15, 18) . Commercially available staphylocoagulase preparations can be used. In that case the own amidolytic activity of the preparation should be determined and its activating capacity has to be checked on normai pooled plasma.
Results
Experimental
The method that we propose here has the purpose to determine the velocity of prothrombin conversion in whole plasma. To this end we determine the amidolytic activity that generates and disappears in plasma after suitable triggering of the coagulation process, using a substrate specific for thrombin. Then we analyse the time-activity curve by a mathematical procedure that separates the process of thrombin formation (prothrombinase activity) and thrombin inactivation (antithrombin activity). In order to carry out the calculations it is necessary to know the Thble I Activities and concentrations of orM-thrombin and prothrombin ln serum Activities (nM thrombin eq) The dotted lines represent the thrombin generation velocities of the ll40 and 1/400 curves resp. The scale for these curves is the thrombin generation velocity in nM.min-t reaction constants of the breakdown processes. In the first part of this section we will discuss how these data are obtained. In the second part we verify the mathematical model.
I. The Thrombin Generation Curve and the Reaction Constants
Fig . 1 shows the thrombin activities generated in normal plasma by different dilutions of tissue thromboplastin. As a rule the standard derivation of each point is below 4o/" except for the points located in the steep rising parts of the generation curve. With the aid of pipettes provided with a signalling pushbutton connected to an input port of an Apple IIe computer we could estimate the experimental error in the sampling time to be between 0.4 and 1 sec. In the horizontal parts of the curve the coefficient of variation of the thrombin determination is 2.75oh.
When the tangent of the curve is steep, the time error adds significantly to the overall error so as to make it 15-t8% at tangents exceeding 1000 O.D.U. min-1. With the aid of the time recording pipettes it is possible to eliminate the time error and to obtain almost perfectly overlapping curves in repeated experiments.
The amounts of residual prothrombin left in the mixtures after the amidolytic activity has reached a steady end-level, were determined with staphylocoagulase (Table 1) . They are apparently not dependent upon the variations in veiocity of thrombin generation induced by dilution of thromboplastin.
From Fig.2 it appears that thrombin generation can be resumed in the course of the experiment if purified human prothrombin is again added. The method thus determines thrombin generation velocities that are dependent upon both prothrombin concentration and prothrombinase activity. Fig.3 shows experiments in which the breakdown constant of thrombin in plasma was determined. The decay curve of thrombin generated endogenously in plasma was obtained by stopping the factor Xu activity in thrombin generating plasma by addition of SBTI and measuring the thrombin disappearance (see methods section). Alternatively 200 nM of thrombin that had been formed in a euglobulin mixture was added at zeto time to defibrinated plasma diluted in the same way as the reaction mixture, SBTI included. In the latter case the decay was two fold quicker. The slower decay of endogenously formed thrombin cannot be attributed to ongoing thrombin formation because the amount of prothrombin that can be demonstrated with staphylocoagulase in the plasma does not change after the moment of stopping the reaction with SBTI (results not shown). During the course of thrombin generation the decay constant of thrombin does not change (Fig. a) , showing that in the course of the experiment there is not a time-dependent change in the properties of thrombin that could explain the difference in half-life time. For the moment we have no explanation for this phenomenon (see discussion).
The form of the decay curve is adequately described by a Iogarithmic approach to a steady end level (Figs.3 and 4) . From experiments like these overall decay constants can be obtained. This overall constant (k."n) is equal to the sum of the o2M- constant (k2), mainly due to antithrombin III. Table 2 lists these constants for various kinds of normal and deficient plasma. Also, in this table the ratio of the amount of prothrombin consumed during the experiment (i. e. the total amount of thrombin formed) and the amount eventually taken up by o2M is given, as well as the values of k1 and k2 that.can be calculated from these data. For this calculation it is necessary to know the value of f; i. e. the ratio of the amidolytic activity of one mole of the o2M-thrombin complex to one mole of free thrombin. This value was obtained by preparing thrombin in a euglobulin precipitate of defibrinated plasma and estimating its activity. Then an excess of &rr o2rn€lcro-0.240 0.111
Dil.: Dilution due to immunoadsorption, the control plasmas were diluted to the same extent k"*o: Overall decay constant observed (min I) R"*o: Ratio of o2M-T to At III-T in the control plasma kr and k2: Reudo first order reaction constants of the complexation of thrombin with u2M and non-o2M respeclively (min r) 1) Obtained from the double deficient plasma (accounting for the difference in dilution) 2) Obtained by subtracting k1 from k."o globulin preparation devoid of AT III activity was added and the residual amidolytic activity was determined, f was estimated to be 0.558 + 0.043 (n : 10; S.E.M.) (cf. Table 1 ).
II. Verification of the Model
The adequacy of our model was tested in two fundamentally different ways a) by comparing the time course of reaction products as predicted by the model with those actually found, b) by studying the effect of selective elimination of AT III and/or ozM. In Fig.5 two sets of experimental data are plotted. The overall amidolytic activity as determined by our standard procedure (O) and the level of o2M-thrombin (A). The latter was determined by subsampling from the reaction mixture into a solution containing an excess (1 U/ml) of heparin and 20 mM EDTA. In this mixture the generation of thrombin stops immediately and, because the half-life of thrombin is <10 sec, the residual activity measured after 1.0-20 min is due to the amount of c,2M-bound thrombin that was present at the moment of subsampling. From the data on amidolytic activity, with the formulas derived from the mathematical model, one can also calculate the time course of the o2M-thrombin concentration (O). From Fig.5 it is seen that the calculated values and the values actually determined coincide within the limits of experimental error. Fig. 6 also shows the equivalence of a set of experimental and calculated concentrations, viz. those of the total amounts of prothrombin converted into thrombin. Experimentally these conientrations were determined by subsampling into a mixture containing 20 mM EDTA, 1 U/ml of heparin and 2pM of staphylocoagulase. In this mixture prothrombin conversion into thrombin stops, the thrombin present is inactivated by AT III and the prothrombin present converts quickly (second order rate constant 3.3 x 106M 1s-1; [12] into the amidolytically active prothrombin-staphylocoagulase complex that is not inactivated by AT III. Thus one obtains the amount of residual prothrombin (after subtraction of the activity due to o2M-thrombin determined independently) while the amount of prothrombin converted into thrombin is found by subtraction from the starting level. The equivalence between the concentrations found experimentally and those derived from the amidolytic activity via the kinetic model is again satisfactory.
A different approach to test the validity of the model is shown in Figs.7 and 8 . Here the inactivation system of the plasma was modified by selective immunoadsorbtion of o,2-macroglobulin and AT III respectively. Control plasmas were obtained by treating normal plasma in a comparable way with a gammaglobulin fraction from serum from non-immunised rabbits and adjustment of the dilution if necessary.
In Thble 2 it is shown that the decay constants calculated for the non-deficient plasma are identical to those found experimentally in the deficient plasmas, if one allows for a small amount of inhibition that is due to neither o2M or AT III.
In Fig.7 the thrombin activity curves obtained with the u,2M deficient plasma and its control are shown as well as the thrombin generation velocity curves obtained from them, using the relevant constants from Table 2 . InFig.8 the same is done for the AT III deficient plasma. In both Fig.7 and Fig. 8 the thrombin generation velocity curves obtained with the deficient and the control plasmas superimpose within the limits of experimental error, as would be expected from the model. The constants used for calculation are siven in Table 2 . T lM E (min.)
analysis and isolation of enzymes with partial reconstruction of the system form its components. In the last ten years the latter approach has yielded important results and the main mechanisms of activation of clotting factors are well known by now. It remains difficult however to answer in this way questions about the relative physiological importance of mechanisms that have been shown to be biochemically possible. What is the importance ln vivo of the extrinsic activation of factor IX? or of the feedback activation of factors V and VIII by thrombin? The question of whether heparin and its derivates inhibit the formation of thrombin in vivo or only accelerate its inactivation is not settled either. As a first step to approach the in vivo situation we developed a method in which the generation of thrombin in whole plasma ("ex vivo") can be studied independently of its breakdown by antiproteases. The method consists of measuring the course of amidolytic activity after triggering thrombin formation in a sample of defibrinated plasma and then eliminating the effect of the breakdown processes by compensating for their velocities, that are calculated from the concentration of thrombin and the breakdown constants. The calculations are easily carried out on a personal computer.
The problem with this approach is that the acceptability of the results obtained is entirely dependent upon the acceptability of the model and the mathematical procedure. Therefore it is important to test extensively the validity of the method.
We assume that the situation in the plasma when thrombin generates can be depicted by the following diagram: prothrombinase lk' ' prothrombin -+ thrombin --+ cr2M-thrombin inactive,*"T0,'
The assumptions at the basis of the kinetic model are:
1. Thrombin breakdown occurs via two processes, one (caused by AT III and others antiproteases) leading to inactive products, the other (o2M-dependent) leading to a product with a residual amidolytic activity. 2. Both reactions are of pseudo first order with regard to thrombin. It has been demonstrated that the interaction of AT III with thrombin is a bimolecular reaction and shows second order kinetics (I9,20) . Under the conditions prevailing in our experiments there is at least a ten-fold excess of AT III over free thrombin and the excess of a.1-antithrombin is a hundred-fold. It therefore seemed reasonable to try whether a model for this reaction based on pseudo first order kinetics would stand verifica_ tion. The case of o2M-dependent inactivation is more complex. Here the stoichiometry of the reaction is variable and the kinetics of the reaction are complicated (20, (6) (7) (8) (9) (10) , yet second order reaction kinetics describe the situation if the o2M to thrombin ratio is higher than 2 ro 1 (20) . The initial concentration of o2M is 2 pM. No more than 300 nM of this is complexed in the course of the experiment (Figs. 1 and 5) . As a fiist approximation we therefore again assumed pseudo first order kinetics. If, or to what extent it is indeed an adequate description of this situation must follow from the experiments.
The translation of the reaction model into rate equations, the solution of these equations and their utilization in a computer program is a technical problem in mathematics, that is explained in the annexe and will not be discussed here.
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The following qualitative arguments support the correctness of the model:
a. The partition between the AT III-II" complex and the o2M-IIu complex of the thrombin generated in an experiment is independent of the course of thrombin generation. This can be seen in Fig. 1 and Table 1 , where the total amount of prothrombin. as well as the levels of o2M-IIu eventually obtained are indepen_ dent of the dilution of thromboplastin used. Our model pr"di.t, such behaviour (formula 8).
b. The decay of thrombin activity is characterized by a logarithmic approach to a steady end-level (Fig.3) . This proves the pseudo first order character of the breakdown constants (formula 4c).
c. The breakdown constant of thrombin does not change over the experiment (Fig. 4) .
d. The level of activity remaining in the plasma after activation is explained by the level of o2M-IIu present (Fig. 5) , in the absence of o2M, the activity approaches the zero level (Fig.7) .
In the absence of both o,2M and AT III there is a residual antithrombin activity of about 18% of the total (Thble 2). This activity is not heparin dependent and consumes thrombin in a pseudo first order process (results not shown). In our formulas this decay is included in the AT III dependent decay (k2). This inhibition activity is presumably due to tr1 antitrypsin and other antiproteases.
From the observations (a to d) it can be concluded that the qualitative features of our model are supported by the experiments. The validity of our model is further corroborated by the similarity of the concentration courses calculated and those actually observed. In principle the time courses of all the reactants can be computed from the time course of the amidolvtic activitv. In practise the amounts of remaining prothrombin and of the a2M-thrombin complex can be determined independent of amidolytic activity, thus offering the opportunity to compare the results of the calculation with the time-course of concentrations actually found. Figs.5 and 6 shows that the observed and the computed points seem to follow the same curve.
Further qualitative arguments for the correctness of our procedure can be derived from Figs.7 and 8. Here it is seen that the velocities of thrombin generation computed from plasmaspecifically deficient in either o2M or in AT III coincidi with those of the control plasma if the respective breakdown constants are eliminated from the computation.
We conclude that, within the limits of experimental error our model gives a satisfactory description of the situation in plasma and that our procedure can be used to obtain thrombin seneration velocities from amidolytic activities. The use of the computer in this procedure is not unlike that of the microscope in that it can reveal experimental features not apparent at direct inspection.
Several observations await explanation: 1. The lag time always observed when thromboplastin is used as a trigger. It has to be determined whether feedback activations by thrombin of factor V and/or VIII contribute to this process.
2. The difference in breakdown velocity of endogenously generated thrombin and of exogenous thromtin. The ge'neration of meizothrombin (21, 17) or any other amidolytic thrombin precursor with a low affinity to antiproteases does not offer an explanation because it would, in the course of the experiment; convert into thrombin, so that the apparent decay constant found would increase during the experiment and approach that of free thrombin, which it does not (Fig. a) . One can surmise that part of the freshly formed thrombin is inaccessible to antiprotease action because it still interacts with elements of the prothrombinase complex and/or its own activation peptides. The itrong noncovalent interactions between the N terminal half of prothrombin (fragment 'J., 2) and the C terminal half (prethrombin 2, thrombin) (22) make such interactioirs not a priori unlikely. This problem is at present under investigation. The same phenomenon probably explains why the pseudo order rate constants that we find for endogenous thrombin,breakdown in whole plasma are below the lower limits of ranges found in the literature with free thrombin and in (partly) purified systems. For o2M we found 0.342 min-I (Table 1) 3. The model behaves as if the inhibitory capacity of o2M is immediately available, although it is known that this molecule has to be activated by a proteolytic enzyme, e.g. by the proteolytic enzyme that it will complex with (5, 6 and references therein).
4. Even though prothrombinase is not exhausted (Fig.2) , the reaction comes to a stop when 5-I0% of the original prothrombin is left. This suggests the possibility of product inhibition of prothrombin activation in whole plasma. Our results indicate that in 2:3 diluted normal platelet free plasma-(our standard system) the pseudo first order rate constant of o2M, AT III and non-o2M-non-ATIII antiproteases contribute 23%, 64% and 13% to the overall disappearance rate of endogenous thrombin. This is in accordance with the 20-30% of plasma antithrombin activity assigned to a2M by several authors (10, 19, 20) .
We think that our method may be a valuable means to investigate the physiology of thrombin generation in whole plasma and to study the influence of antithrombotic drugs on, as well as the pathological changes of this process. In the latter case additional studies, such as the estimation of prothrombin activation peptides may be necessary.
The procedure we propose can also be applied to the study of the factor X generating enzyme (Factor IXu -Factor VIII^ -Phospholipid) in plasma on basis of the factor Xu levels observed. The amidolytic activity that we observe in the experiment is the sum of the activities of free thrombin and o2M-bound thrombin. The experimental procedure gives this activity at a series of points in time. It is our purpose to obtain the velocity of thrombin generation alone as a function of time [g(t)], independent of the breakdown processes.
We can make no assumptions as to the form of g(t) because the enzyme that causes prothrombin activation (prothrombinase) itself increases and decreases as an unknown function of time. We describe the disappearance of thrombin as the sum of two pseudo first order reactions, one giving the inactive product of the interaction of antithrombin III and thrombin (AT III-T) and minor amounts of other inactive forms of thrombin and the other the amidolytically active complex of o2-macroglobulin and thrombin (o2M-T). (see discussion for experimental justification).
The chemical model can be represented by a set of differential equations that describes the relations between the reaction velocities and the concentrations of the reactants in the svstem. We will use the following symbols: A(t) : amidolytic activity found at time t P(t) : prothrombin concentration at time t T(t) : thrombin concentration at time t M(t) : o.2M-thrombin concentration at time t g(t) : thrombin generation from prothrombin as a function of time A(t) : ! s (k,+kd(t-',*r {E:, ttO[r-" ru'*o,rt : pseudo first order rate constant for thrombin to AT III f : the ratio of the.enzymatic activity of one mole of o2M-T over that of one mole of thrombin The subcripts thr and mcr will indicate the activities due to thrombin and to o2M-thrombin respectively, the total activity is unsubscripted.
The amidolytic activity will be expressed in thrombin equivalent-amounts, so that A : T in a solution containing only thrombin and A : f.M in the presence of o2M-thrombin only.
At any moment the net velocity of thrombin formation will be equal to the sum of the velocity of thrombin generation from prothrombin and the velocity of thrombin breakdown: 
